United States Pharmecutic is categorized under Pharmaceutical Manufacturing Plant Construction in Sacramento, CA and active since 2001.
United States Pharmecutic was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Manufacturing Plant Construction business, which does work in the B2B market, and is classified as a Pharmaceutical Manufacturing Plant Construction, under code number 236220 by the NAICS.
If you are seeking more information, feel free to contact Unkniown Unkniown at the company’s single location by writing to 4732 Crestwood Way, Sacramento, California CA 95822 or by phoning (916) 498-0452. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | United States Pharmecutic |
Contact Person: | Unkniown Unkniown |
Address: | 4732 Crestwood Way, Sacramento, California 95822 |
Phone Number: | (916) 498-0452 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Pharmaceutical Manufacturing Plant Construction |
SIC Code: | 1541 |
NAICS Code: | 236220 |
Share This Business: |
United States Pharmecutic was started in 2001 to provide professional Pharmaceutical Manufacturing Plant Construction under the SIC code 1541 and NAICS code 236220. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Unkniown Unkniown for inquiries that concern United States Pharmecutic by calling the company number (916) 498-0452, as your correspondence is most welcome. Additionally, the physical location of the single location of United States Pharmecutic can be found at the coordinates as well as the street address 4732 Crestwood Way in Sacramento, California 95822.
For its online presence, you may visit United States Pharmecutic’s website at and engage with its social media outlets through on Twitter and on Facebook.